NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 232 filers reported holding NOVAVAX INC in Q1 2023. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $289,926 | +481.1% | 22,901 | +120.3% | 0.00% | – |
Q4 2023 | $49,895 | -91.8% | 10,395 | -87.6% | 0.00% | -100.0% |
Q3 2023 | $606,284 | +32.5% | 83,741 | +88.2% | 0.01% | +25.0% |
Q4 2022 | $457,460 | -87.6% | 44,500 | -78.1% | 0.00% | -87.1% |
Q3 2022 | $3,704,000 | +16.7% | 203,459 | +229.6% | 0.03% | 0.0% |
Q2 2022 | $3,174,000 | +58.5% | 61,728 | +127.1% | 0.03% | +72.2% |
Q1 2022 | $2,002,000 | +112.8% | 27,182 | +313.5% | 0.02% | +100.0% |
Q4 2021 | $941,000 | -65.6% | 6,574 | -49.0% | 0.01% | -69.0% |
Q2 2021 | $2,738,000 | – | 12,900 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 3,002,087 | $544,308,000 | 8.21% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 323,517 | $58,657,000 | 7.86% |
Samsara BioCapital, LLC | 198,600 | $36,008,000 | 6.64% |
Foresite Capital Management I, LLC | 66,810 | $12,113,000 | 6.11% |
Foresite Capital Management II, LLC | 67,373 | $12,215,000 | 2.81% |
SECTORAL ASSET MANAGEMENT INC | 191,200 | $34,666,000 | 2.63% |
Rock Springs Capital Management LP | 461,000 | $83,584,000 | 1.82% |
TSP Capital Management Group, LLC | 23,525 | $4,265,000 | 1.50% |
Ikarian Capital, LLC | 195,700 | $35,483,000 | 1.19% |
SevenOneSeven Capital Management | 1,744 | $316,000 | 1.16% |